Annex

Each rabbit has been continuously resident in New Zealand for six months prior to export or since birth.

No case of the disease Tularaemia (Francisella tularensis) has been diagnosed in the country of origin in the two years prior to certification.

There is no evidence of the following diseases or infectious agents at the premises where the companion rabbit has resided during the 12 months prior to export:
3.1. Treponema cuniculi (treponematosis).
3.2. Encephalitozoon cuniculi (encephalitozoonosis).
3.3. Yersinia pestis (sylvatic plague).
3.4. European brown hare syndrome.
3.5. rabbit enterocolitis.

During the four days immediately prior to export each rabbit was treated for fleas and ticks using an effective insecticide in accordance to manufacturer directions.
Note: Active ingredient and dose must be recorded on the Veterinary Certificate.

Each rabbit for export has:

5.1. Not been vaccinated for myxomatosis, or

5.2. If vaccinated, the rabbit was vaccinated for myxomatosis using an approved vaccine containing live Shope Fibroma virus or with an inactivated vaccine a minimum of six months prior to export.

Each rabbit is implanted with an ISO compliant microchip. The microchip number and implantation site is recorded on the veterinary certificate.

Each rabbit was examined by an official veterinarian during the 48 hours immediately prior to export and was found to be:
7.1. Clinically healthy and free from evidence of infectious or contagious diseases and visible, palpable tumours.
7.2. Free from external parasites.
7.3. Fit to travel.

All other rabbits on the premises of origin were inspected and found to be clinically healthy and free from evidence of infectious or contagious diseases and external parasites during the 48 hours immediately prior to the rabbit(s) being exported.